IPO Flurry Continues: Receptos Files Proposed $86M Offering

By Jennifer BoggsManaging Editor

Friday, April 5, 2013

Receptos Inc. became the seventh U.S. biotech to file for an IPO this year, taking advantage of the emerging growth company provision in the Jumpstart Our Business Start-ups Act and aiming to raise as much as $86.3 million to support clinical work in multiple sclerosis, inflammatory bowel disease and allergic/immune-mediate disorders.